Jobs From Millennium Pharmaceuticals

About Millennium Pharmaceuticals
Millennium Pharmaceuticals, Inc., was established in 1993 as a genomics company applying world-class recombinant technology to the discovery and development of innovative new therapies in a broad spectrum of diseases. Millennium has since grown into a fully integrated biopharmaceutical company with a pipeline of investigational drug candidates, as well as VELCADER (bortezomib) for Injection, a successfully commercialized medicine derived from Nobel Prize-winning science that is now approved in more than 87 countries worldwide.

In May of 2005, the company's leadership changed as Founder Mark Levin turned the helm over to his carefully selected successor, Deborah Dunsire, M.D. Although considered remarkably different in management style, Dunsire embraced the company's culture, and had the skills and experience Levin and the Board of Directors considered necessary to move the company forward to greater accountability and sustainable success.

For the next several years, significant refocusing and reconfiguration took place within Millennium, as well as considerable improvements in the scale and strength of Commercial Operations.

In May, 2008, Millennium was acquired by Takeda Pharmaceutical Company Limited. Takeda is the largest pharmaceutical company in Japan, and a global enterprise with an important presence in key markets.

Millennium now operates as an independent subsidiary, serving as the global center of excellence in oncology under its new name: "Millennium: The Takeda Oncology Company." The merger of oncology resources has resulted in a more robust pipeline of investigational drug candidates.

This new function focuses Millennium efforts on expanding its scope of responsibility to the global oncology community. Along with an increased capacity in oncology comes increased accountability for success and a new mission that puts Millennium on a trajectory toward global oncology leadership.

This global footprint includes oncology research and marketing strategy and oversight. In addition to Cambridge, MA, oncology resources include facilities in San Diego, San Francisco, Tsukuba and Osaka with Millennium as the global hub for this critical and rapidly expanding therapeutic area.